# Putnam U.S. Research A (PNRAX)

> Source: Nexqual · https://nexqual.com/PNRAX · data as of 2026-10-24 00:08 UTC · cite as "Nexqual, Putnam U.S. Research A (PNRAX), nexqual.com/PNRAX" · informational, not investment advice.

**Price:** USD 64.06 (-0.42% on the day) · last close of Oct 23, 2026; US market closed, not a live price. Prev close 64.33 · day 64.06–64.06 · 52w 52.48–65.75 · market cap null · NAS

## Key facts
- Total return with dividends: 1Y +16.3% vs S&P 500 +13.4%; 5Y +83.5% vs S&P 500 +76.9%.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-24) | 5Y (from 2021-10-25) |
|---|---|---|
| Total return | +16.3% | +83.5% |
| S&P 500 (SPY) | +13.4% | +76.9% |
| Per year | +16.4% | +13.0% |
| Volatility (annualized) | 13.1% | 16.3% |
| Max drawdown | -8.2% (Jan 2026→Mar 2026) | -24.4% (Nov 2021→Sep 2022) |

## Peers
POGAX (Putnam Growth Opportunities Fun) USD 76.22 -0.00% · POVSX (Putnam International Equity Fd ) USD 33.31 -0.00% · PHSTX (Putnam Global Health Care Fund ) USD 68.4 -0.00% · PGEOX (George Putnam Balanced Class A) USD 28.9 +0.00% · PSLAX (Putnam Small Cap Value A Shares) USD 17.87 -0.00%

## More
Full page: https://nexqual.com/PNRAX · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt